In Volatile Times, Select CEOs for Strategic Advantage, Not Safety The “safe” approach to succession can be counterproductive. Here are three strategies for boards to transform CEO selection into strategic advantage.
2026 Biopharma Leadership Outlook: 4 Trends and What They Mean for Leaders Spencer Stuart’s 2026 Biopharma Outlook looks at the four key industry trends and what they mean for the year ahead.
2025 S&P 1500 CEO Transitions Our annual analysis of CEO transitions, tenure and backgrounds among S&P 1500 companies, including breakdowns by large-, mid- and small-cap companies.
CEO Transitions: How to Avoid a Bumpy Exit Current and former CEOs share their views on CEO tenure, the elements of a smooth transition and life after the CEO role.
How leaders are navigating the changing biopharmaceutical supply chain The biopharmaceutical chain has been pushed to new limits in recent years. We report on the recent CHPI conference in Barcelona and set out our perspective on the top trends and their leadership implications.
Sharing Their Stories: The Factors Senior Women of Color Leaders Say Made the Difference in Their Careers Often the “first and only” woman of color in senior roles and executive spaces, high-achieving women of color share advice and stories about their careers.
Closing the Confidence Gap: Why the Board-CEO Relationship Needs a Reset CEOs are more equipped to deliver long-term value creation when their board balances accountability with support. Here’s how to get the balance right.
Defining a New Model for Board-CEO Engagement While there is no one-size-fits-all model for an effective board-CEO relationship, directors and CEOs told us what has worked for them.